PASQUALIN, LUCA
 Distribuzione geografica
Continente #
EU - Europa 201
AS - Asia 132
NA - Nord America 103
SA - Sud America 13
AF - Africa 5
Totale 454
Nazione #
RU - Federazione Russa 137
US - Stati Uniti d'America 96
SG - Singapore 63
IT - Italia 25
CN - Cina 20
HK - Hong Kong 17
DE - Germania 13
BR - Brasile 11
VN - Vietnam 11
GB - Regno Unito 6
ID - Indonesia 6
CA - Canada 5
FR - Francia 5
KR - Corea 4
NL - Olanda 4
JP - Giappone 3
AT - Austria 2
BD - Bangladesh 2
BJ - Benin 2
FI - Finlandia 2
PL - Polonia 2
TG - Togo 2
BE - Belgio 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
KE - Kenya 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 454
Città #
Moscow 46
Singapore 27
Ashburn 22
Dallas 22
Hong Kong 17
Verona 9
Munich 8
Los Angeles 6
Beijing 4
New York 4
Chicago 3
Kebon Manggis 3
Milan 3
Padova 3
Redondo Beach 3
The Dalles 3
Tokyo 3
Amsterdam 2
Brooklyn 2
Columbus 2
Cotonou 2
Haiphong 2
Hanoi 2
Helsinki 2
Jakarta 2
Lomé 2
London 2
Meda 2
Montreal 2
Naples 2
Nuremberg 2
Perugia 2
Rome 2
Stanford 2
Warsaw 2
Augusta 1
Baghdad 1
Barcelona 1
Barreiros 1
Bauru 1
Biên Hòa 1
Blumenau 1
Brejões 1
Brussels 1
Buffalo 1
Bình Dương 1
Bắc Giang 1
Campinas 1
Castanhal 1
Charlotte 1
Chennai 1
Council Bluffs 1
Da Nang 1
Denver 1
Dhaka 1
Dublin 1
Frankfurt am Main 1
Ho Chi Minh City 1
Khulna 1
Louisville 1
Miami 1
Nairobi 1
Newcastle upon Tyne 1
Orland Park 1
Phoenix 1
Phú Thọ 1
Pitangueiras 1
Querétaro 1
Sambir 1
Santa Clara 1
Santo André 1
Santo Domingo 1
Semarang 1
Senador Firmino 1
Seoul 1
São Paulo 1
Tashkent 1
Thái Bình 1
Toronto 1
Torres 1
Washington 1
Totale 268
Nome #
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 117
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 81
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 79
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 78
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 59
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 48
Totale 462
Categoria #
all - tutte 1.800
article - articoli 1.800
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 3 2
2023/202426 0 1 3 2 1 2 6 3 0 1 4 3
2024/2025126 12 2 11 22 8 7 5 2 18 2 13 24
2025/2026305 20 14 22 95 128 26 0 0 0 0 0 0
Totale 462